Jefferies Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.3M Buy
508,740
+373,505
+276% +$21.4M 0.19% 102
2026
Q1
$8.2M Sell
135,235
-370,538
-73% -$21.6M 0.06% 238
2025
Q4
$27.3M Buy
505,773
+381,724
+308% +$18.4M 0.14% 143
2025
Q3
$5.59M Buy
124,049
+51,616
+71% +$2.41M 0.03% 341
2025
Q2
$3.35M Buy
72,433
+22,282
+44% +$1.09M 0.03% 399
2025
Q1
$3.06M Sell
50,151
-196,877
-80% -$11.5M 0.03% 439
2024
Q4
$14M Sell
247,028
-31,594
-11% -$1.77M 0.08% 178
2024
Q3
$14.4M Buy
278,622
+47,568
+21% +$2.23M 0.1% 122
2024
Q2
$9.6M Buy
231,054
+111,992
+94% +$5.01M 0.1% 162
2024
Q1
$6.46M Sell
119,062
-76,577
-39% -$3.9M 0.06% 249
2023
Q4
$10M Buy
195,639
+65,723
+51% +$3.45M 0.07% 223
2023
Q3
$7.54M Buy
129,916
+102,023
+366% +$6.25M 0.07% 232
2023
Q2
$1.78M Sell
27,893
-154,100
-85% -$10.3M 0.02% 698
2023
Q1
$12.6M Buy
181,993
+122,993
+208% +$8.67M 0.1% 173
2022
Q4
$4.25M Buy
+59,000
New +$4.45M 0.03% 447

Other funds holding BMY

Jefferies Financial Group's BMY Position: Q2 2026 in Review

Jefferies Financial Group increased its Bristol-Myers Squibb (BMY) stake by 276% in Q2 2026, buying an estimated $21.4M and bringing the position to 508,740 shares worth $29.3M. The position accounts for 0.19% of the portfolio, ranked #102.

Jefferies Financial Group first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Jefferies Financial Group held 508,740 shares of Bristol-Myers Squibb worth $29.3M as of Q2 2026.
  • Jefferies Financial Group bought 373,505 Bristol-Myers Squibb shares in Q2 2026, an estimated $21.4M.
  • Bristol-Myers Squibb made up 0.19% of Jefferies Financial Group's portfolio in Q2 2026, its #102 holding.
  • Jefferies Financial Group first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.